Antithrombotic therapy in atrial fibrillation: stop triple therapy and start optimizing dual therapy?
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Research in Cardiology"
DOI: 10.1007/s00392-019-01496-w
Abstract: Based on recent studies, we want to provoke thoughts on how to further optimize research on antiplatelet treatment in patients on oral anticoagulation (OAC). One in three patients suffering from atrial fibrillation (AF) develops concomitant… read more here.
Keywords: atrial fibrillation; trial; analysis; dual therapy ... See more keywords
Clinical impact of vonoprazan-based dual therapy with amoxicillin for H. pylori infection in a treatment-naïve cohort of junior high school students in Japan
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Gastroenterology"
DOI: 10.1007/s00535-020-01709-4
Abstract: Although 7-day triple therapy, consisting of vonoprazan, amoxicillin (AMO), and clarithromycin (CLA), is recommended for Helicobacter pylori (H. pylori) eradication in adults. However, the importance of reducing antibiotic use in pediatric patients is well recognized.… read more here.
Keywords: junior high; dual therapy; triple therapy; vonoprazan ... See more keywords
The Future of Triple Therapy in chronic obstructive pulmonary disease.
Sign Up to like & getrecommendations! Published in 2017 at "Archivos De Bronconeumologia"
DOI: 10.1016/j.arbr.2017.12.003
Abstract: The pharmacological treatment of chronic obstructive pulmonary disease (COPD) focuses on 2 main objectives: controlling symptoms (in the form of reduced symptoms, improved exercise tolerance, and better quality of life) and reducing future risk (understood… read more here.
Keywords: combination; chronic obstructive; obstructive pulmonary; triple therapy ... See more keywords
The clinical implications of triple therapy in fixed-dose combination in COPD: from the trial to the patient
Sign Up to like & getrecommendations! Published in 2020 at "Archivos De Bronconeumologia"
DOI: 10.1016/j.arbr.2020.02.002
Abstract: The emergence of a fixed-dose combination (FDC) of a long-acting β2-agonists (LABAS), a long-acting anticholinergic agent (LAMA), and an inhaled corticosteroid (ICS) in a single inhalation device has changed the approach to inhaled therapy. Although… read more here.
Keywords: fixed dose; dose combination; efficacy; triple therapy ... See more keywords
Triple Therapy vs. Triple Therapy in COPD.
Sign Up to like & getrecommendations! Published in 2017 at "Archivos de bronconeumologia"
DOI: 10.1016/j.arbres.2017.01.020
Abstract: The combination of 2 long-acting bronchodilators, a 2-agonist (LABA), and an antimuscarinic agent (LAMA) in a single inhalation device, known as double bronchodilation,1 has changed therapeutic strategies in chronic obstructive pulmonary disease (COPD). Studies evaluating… read more here.
Keywords: combination; double bronchodilation; copd; triple therapy ... See more keywords
PREDICTORS OF FREQUENT EXACERBATIONS IN COPD PATIENTS ON TRIPLE THERAPY: CASE CONTROL STUDY FROM INDIA
Sign Up to like & getrecommendations! Published in 2019 at "Chest"
DOI: 10.1016/j.chest.2019.08.1484
Abstract: SESSION TITLE: Wednesday Abstract Posters SESSION TYPE: Original Investigation Posters PRESENTED ON: 10/23/2019 09:45 AM 10:45 AM PREDICTORS OF FREQUENT EXACERBATIONS IN COPD PATIENTS ON TRIPLE THERAPY: CASE CONTROL STUDY FROM INDIA RAHUL SHARMA MD,… read more here.
Keywords: exacerbations copd; frequent exacerbations; copd patients; study ... See more keywords
The Role of Double and Triple Therapy with Direct Oral Anticoagulants in Coronary Artery Disease, Peripheral Artery Disease, and Stroke.
Sign Up to like & getrecommendations! Published in 2018 at "Clinical therapeutics"
DOI: 10.1016/j.clinthera.2018.09.014
Abstract: PURPOSE Combining antiplatelet and anticoagulant therapy is often necessary in clinical practice. However, there is limited literature on tolerability and efficacy for triple therapy with the newer direct oral anticoagulants (DOACs). The objective of this… read more here.
Keywords: therapy; antiplatelet; triple therapy; artery disease ... See more keywords
Outcomes of left ventricular thrombosis in post-acute myocardial infarction patients stratified by antithrombotic strategies: A meta-analysis with meta-regression.
Sign Up to like & getrecommendations! Published in 2021 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2020.12.087
Abstract: BACKGROUND Left ventricular thrombus (LVT) formation is a significant complication of acute myocardial infarction (AMI) due to its embolic potential. However, managing LVT requires balancing therapeutic benefits against bleeding risks. Our study provides a risk-benefit… read more here.
Keywords: anticoagulation; analysis; triple therapy; post ... See more keywords
Adjunctive therapy with vitamin c and thiamine in patients treated with steroids for refractory septic shock: A propensity matched before-after, case-control study.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of critical care"
DOI: 10.1016/j.jcrc.2020.04.014
Abstract: PURPOSE Triple therapy with steroids, vitamin C and thiamine has been recently proposed as a safe and beneficial in patients with sepsis. In 2017, we added the use of intravenous vitamin C and thiamine in… read more here.
Keywords: patients treated; vitamin thiamine; septic shock; triple therapy ... See more keywords
A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol.
Sign Up to like & getrecommendations! Published in 2019 at "Respiratory medicine"
DOI: 10.1016/j.rmed.2019.08.010
Abstract: BACKGROUND Single inhaler triple therapies providing an inhaled corticosteroid, a long-acting muscarinic antagonist, and a long-acting β2-agonist (ICS/LAMA/LABAs) are an emerging treatment option for chronic obstructive pulmonary disease (COPD). Nevertheless, questions remain regarding the optimal… read more here.
Keywords: moderate severe; study; formoterol fumarate; severe copd ... See more keywords
Therapeutic effectiveness and safety of sintilimab-dominated triple therapy in unresectable hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-98937-2
Abstract: Immune checkpoint inhibitor therapy has shown promising results in patients with unresectable hepatocellular carcinoma. This study aimed to evaluate the effectiveness and safety of sintilimab, a programmed cell death protein-1 (PD-1) blockade, combined with sorafenib… read more here.
Keywords: hepatocellular carcinoma; group; unresectable hepatocellular; triple therapy ... See more keywords